{
    "title": "Japan gives priority review status to Alzheimer's drug developed by Eisai, Biogen",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11690717/Japan-gives-priority-review-status-Alzheimers-drug-developed-Eisai-Biogen.html",
    "date": "2023-01-30",
    "keywords": [
        "priority",
        "drug",
        "review",
        "status",
        "jan",
        "statement",
        "treatment",
        "approval",
        "disease",
        "drugmaker",
        "co",
        "ltd",
        "biogen",
        "inc",
        "ministry",
        "health",
        "labour",
        "welfare",
        "lecanemab",
        "antibody",
        "protein",
        "beta",
        "japan",
        "utility",
        "target",
        "period",
        "application",
        "latestage",
        "study",
        "rate",
        "decline",
        "placebo",
        "approach",
        "month",
        "eisai",
        "food",
        "administration",
        "fda",
        "reporting",
        "baranjot",
        "kaur",
        "bengaluru",
        "editing",
        "stephen"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}